Home    What We Do   Why Outsource   Who We Are    In the News   Articles   Contact
Regulatory Affairs     International Services     Project Management
Design Control & Documentation     Quality Assurance     Product Development

Press Releases

Company News  |  Press Releases  |  Media Coverage

Recent press releases from BioTechnology Transfer

Former StemCo executive launches BioTechnology transfer
Story carried by:
Triangle dBusiness News

Carolina News Wire

03/09/2006 -- RALEIGH, NC – Cynthia Pritchard, Ph.D., announced the launch of BioTechnology Transfer, a Triangle-based company that provides outsourced strategic product development and regulatory submissions for early-stage life science and medical device companies. The company's scientists and engineers specialize in designing, developing, implementing and supporting practical systems that meet FDA, ISO and ICH quality standards and regulatory requirements.

"BioTechnology Transfer fulfills a large, unmet need for outsourced product development and regulatory submission services in this area," said Pritchard. "Our comprehensive services enable biotech companies to determine concept feasibility, develop marketable products and build their business efficiently."

Pritchard is CEO and a founder of BioTechnology Transfer, bringing more than 25 years' experience in the medical device and diagnostic industries to the company. She was most recently director of development for StemCo Biomedical (now Aldagen), leading the product development and new applications groups.

"I became familiar with Cynthia's high level of skill and knowledge through her work at StemCo," said Garheng Kong, M.D., Ph.D., of Intersouth Partners. "There is a definite need for the types of services BioTechnology Transfer will deliver to start-ups in the Research Triangle Park area. Growing companies that need to move their products quickly from concept to market could certainly benefit from help like this."

Billy Usrey, former operations director of Apogee Medical, will serve as COO. He specializes in due diligence and system assessment for potential investors, equipment validation, and lab and pilot manufacturing design/build to federal and global quality system requirements.

About BioTechnology Transfer
BioTechnology Transfer provides the clear translation necessary to effectively transition ‘blue sky' research concepts into marketable products. We incorporate quality assurance and regulatory requirements up front into research and development, clinical trials and manufacturing to shorten product development and regulatory cycles and lower costs. Our principal scientists and engineers have more than 100 years of combined experience in medical devices, diagnostics, cell therapies and biologics. Together, they have brought more than 50 products to market and have made more than 25 successful submissions to global regulatory agencies. For additional information, please visit www.biotechtrans.com.

Former StemCo Exec Launches Firm To Assist Life Science Startups
Story carried by:
WRALLocalTechwire

03/09/2006 -- RALEIGH, NC – Cynthia Pritchard, a former executive with StemCo, is launching a new company to assist life science and medical device startup firms with product development and regulatory submission services.

The firm, called BioTechnology Transfer, is based in Raleigh. Pritchard is its chief executive officer.

"BioTechnology Transfer fulfills a large, unmet need for outsourced product development and regulatory submission services in this area," said Pritchard, who was director of development for StemCo before launching the new venture. "Our comprehensive services enable biotech companies to determine concept feasibility, develop marketable products and build their business efficiently."

Bill Usrey, a former operations director of Apogee Medical, is the company’s chief operating officer.

BioTechnology Transfer: www.biotechtrans.com

Media Contact
BioTechnology Transfer, LLC
1016 Tobiano Lane
Raleigh, NC 27614
Tel: 919.676.6185, office
919.740.0041, cell
FAX: 919.277.0540
Email: CPritchard@biotechtrans.com